HealthSource review

The four-week cycle is the whole story here, and this seller handles it about as well as a four-week cycle can be handled: the words every 4 weeks sit on the figure, on every single product, so nobody can mistake any of them for a monthly rate. That is the opposite of the usual pattern, where the cadence hides in a terms page and shows up as a thirteenth charge nobody budgeted for. What good disclosure does not change is the arithmetic. Thirteen four-week periods fit into a year rather than twelve, so every figure on this site costs roughly nine per cent more over twelve months than its face value suggests, and the gap grows with the price — on the oral tirzepatide line it runs to several hundred dollars a year. Every figure is a floor besides, with variants selected further into the product page, so the number on the card is the cheapest configuration rather than the price you will pay. No milligram appears anywhere.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

HealthSource says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

The four-week cycle is the whole story here, and this seller handles it about as well as a four-week cycle can be handled: the words every 4 weeks sit on the figure, on every single product, so nobody can mistake it for a monthly rate. That is the opposite of the usual pattern, where the cadence hides in a terms page and turns up as a thirteenth charge nobody budgeted for. What it does not change is the arithmetic. Thirteen four-week periods fit into a year, not twelve, so every figure on this site costs roughly nine per cent more over twelve months than its face value suggests, and the gap grows with the price — on the oral tirzepatide line it is a few hundred dollars a year. Every figure is a floor besides, with variants selected further into the product page, so the published number is the cheapest configuration rather than the price. No milligram appears anywhere.

Every price bills thirteen times a year, not twelve — about 8.7% more than it looks.

• Every figure is a floor, with the real price set by variants further in.
• No milligram appears against any product.

HealthSource is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose